<DOC>
	<DOCNO>NCT01409239</DOCNO>
	<brief_summary>Glycemic variability associate mortality hospitalize patient hyperglycemia . However , unknown modulation glycemic variability would impact outcomes . One possibility glycemic variability could impact autonomic tone . In particular , heart rate variability ( HRV ) measurement sensitive marker measure autonomic tone , aberration HRV associate mortality . The current randomized pilot study compare effect continuous intravenous ( IV ) insulin subcutaneous basal bolus insulin glycemic variability autonomic tone hospitalize non-critically ill patient diabetes . Non-critically ill patient hyperglycemic require least 20 unit insulin per day include . Patients condition preclude accurate HRV reading ( atrial fibrillation pace rhythm ) exclude . Patients randomize intravenous insulin receive therapy 24 hour accord standard hospital guideline . Patients randomize subcutaneous ( SQ ) insulin receive basal bolus therapy use insulin analogue . All therapy begin 8 10 AM . Patients undergo repeated heart rate variability record 24 hour period . Blood draw collect baseline 24 hour measurement catecholamine , insulin , c-peptide . Glycemic variability measure use continuous subcutaneous glucose monitor report coefficient variation . The primary outcome measure low frequency-to-high frequency power spectrum ratio heart rate variability . 1 . Glycemic variability associate unfavorable change autonomic tone , assess low frequency ( LF ) /high frequency ( HF ) HRV ratio , independent change overall glycemia . 2 . Short-term increase glycemic variability , follow prolonged glycemic stability observe generalized hospitalized patient treat intravenous insulin compare standardized basal bolus therapy . LF/HF HRV differs among subject receive intravenous compare subcutaneous insulin . 3 . Glycemic variability differs among subject receive intravenous compare subcutaneous insulin</brief_summary>
	<brief_title>Effect Glycemic Variability Autonomic Tone Hospitalized Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 18 Admitted general medicine medicine subspecialty service Insulin use ( &gt; 20 units/day ) hyperglycemia . Hyperglycemia define glucose great 180 mg/dL least 2 occasion separate least 4 hour apart . Type 1 diabetes Hospital stay expect less 48 hour Inability consent Pregnancy Prisoners Previous participation Autonomic neuropathy Conditions preclude accurate heart rate variability monitoring : atrial fibrillation , frequent ectopy , congestive heart failure , pace heart rhythm Conditions require low dose insulin algorithm : end stage renal liver disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>hospital</keyword>
	<keyword>diabetes</keyword>
	<keyword>glycemic variability</keyword>
	<keyword>autonomic tone</keyword>
</DOC>